Trulicity (dulaglutide) is a protein pharmaceutical. Dulaglutide was first approved as Trulicity on 2014-09-18. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus.
|Indication||type 2 diabetes mellitus|
|Drug Class||Peptides: GLP peptide analogs|